269 related articles for article (PubMed ID: 15077571)
1. [Pancreatic carcinoma and diabetes mellitus].
Krechler T; Novotný J; Zeman M; Krska Z; Svestka T; Sváb J; Lukás M; Filipová R; Zák A
Cas Lek Cesk; 2004; 143(2):97-100. PubMed ID: 15077571
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus in pancreatic cancer follow-up.
Fogar P; Pasquali C; Basso D; Sperti C; Panozzo MP; Tessari G; D'Angeli F; Del Favero G; Plebani M
Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
[TBL] [Abstract][Full Text] [Related]
3. Impaired glucose metabolism in colorectal cancer.
Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
[TBL] [Abstract][Full Text] [Related]
4. [Our experience with pancreatic cancer and its relation to diabetes mellitus].
Krechler T; Zeman M; Vecka M; Jáchymová M; Horejs J; Krska Z; Ulrych J; Dusková J; Zák A
Cas Lek Cesk; 2010; 149(6):291-6. PubMed ID: 20662478
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
Coban E; Sari R; Ozdogan M; Akcit F
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):35-7. PubMed ID: 15662593
[TBL] [Abstract][Full Text] [Related]
6. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis.
Pelaez-Luna M; Takahashi N; Fletcher JG; Chari ST
Am J Gastroenterol; 2007 Oct; 102(10):2157-63. PubMed ID: 17897335
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal metabolism of glucose as clue for early diagnosing pancreatic cancer].
Wu J; Meng X; Li D; Lu H
Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):312-4. PubMed ID: 11953187
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and the risk of pancreatic cancer.
Gullo L; Pezzilli R; Morselli-Labate AM;
N Engl J Med; 1994 Jul; 331(2):81-4. PubMed ID: 8208269
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
Girelli CM; Reguzzoni G; Limido E; Savastano A; Rocca F
Recenti Prog Med; 1995 Apr; 86(4):143-6. PubMed ID: 7617956
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
[TBL] [Abstract][Full Text] [Related]
11. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
Soja AM; Zwisler AD; Frederiksen M; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
Am Heart J; 2007 Apr; 153(4):621-8. PubMed ID: 17383302
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
[TBL] [Abstract][Full Text] [Related]
13. Family history of diabetes and pancreatic cancer.
Egawa N; Tu Y; Sanaka M; Kamisawa T
Pancreas; 2005 Jan; 30(1):15-9. PubMed ID: 15632694
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinemia in patients with colorectal cancer.
Suehiro T; Matsumata T; Shikada Y; Sugimachi K
Hepatogastroenterology; 2005; 52(61):76-8. PubMed ID: 15782998
[TBL] [Abstract][Full Text] [Related]
15. Lens fluorescence in relation to glucose tolerance and genetic predisposition to type 2 diabetes mellitus in a population-based study.
Koefoed Theil P; Kessel L; Hansen T; Lund-Andersen H; Pedersen O; Larsen M
Curr Eye Res; 2006 Sep; 31(9):733-8. PubMed ID: 16966146
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
Schiel R; Müller UA; Braun A; Stein G; Kath R
Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
[TBL] [Abstract][Full Text] [Related]
17. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
18. New-onset diabetes and pancreatic cancer.
Gupta S; Vittinghoff E; Bertenthal D; Corley D; Shen H; Walter LC; McQuaid K
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1366-72; quiz 1301. PubMed ID: 16945591
[TBL] [Abstract][Full Text] [Related]
19. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
20. [Diabetes mellitus and tumors of the oral cavity--epidemiologic correlations].
Ujpál M; Matos O; Bíbok G; Somogyi A; Szigeti K; Szabó G; Suba Z
Orv Hetil; 2004 Apr; 145(14):755-9. PubMed ID: 15131991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
